Project Lucy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Citizen scientists are exploring a body of asteroids called the Trojan to research remnants of the early solar system through NASA's Project Lucy.

A final tip before we get into it. Since cheap stocks tend to move much more robustly than lower-priced fare, you don’t need to spend gobs of money to realize some incredible gains. Indeed, you’re better off just using “dumb money” for these ideas as the wild trading cuts both ways. Cheap Stocks to Buy: Sirius XM (SIRI) Source: Shutterstock Thanks to its vast library of content, Sirius XM represented a fan favorite for many worker bees prior to the pandemic. According to a Washington Post report, the average American lost nearly an hour a week to their commutes. In 2018, this transla...

Shares of Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) hit a new 52-week low of $4.72 on Monday and was trading lower by more than 4 percent. Ariad Pharmaceuticals announced earlier in the day that the U.S. Food and Drug Administration has completed its review of the company's Investigational New... Read More... Don't Miss Any Updates! News Directly in Your Inbox Subscribe to:

Executive Moves Martha Stewart would become an official strategic advisor. Erik Knutson as CEO of cannabis beverage company Keef Brands. Tharp was previously president and COO, and Knutson will remain on the board.  Deals, launches, and IPOs Aurora Cannabis filed for a $300 million stock sale on Thursday. The filing mentions a possibility of a US acquisition, MarketWatch reports.  Cannabis SPAC Mercer Park Brand Acquisition Corp. said on Monday that it has upsized a previously announced equity investment to include $50 million from TPCO Holdings Corp. In total, Mercer Park has raised $135...

MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial News provided by Share this article MindMed Finalizes Clinical Development Approach for LSD Targeting Generalized Anxiety Disorder as Initial Indication NEW YORK, May 17, 2021 /PRNewswire/ -- MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), a leading clinical stage psychedelic medicine company, announces receipt of Type C Meeting Responses from FDA leading to the finalization of the Company's clinical development approach for Project Lucy by selecting Generalized Anxiety Disorder as an initial indication. Mind...